cannabis
CFOs can leverage cannabis related tax strategies and rescheduling benefits to improve margins while preserving the core health and market advantages of the plant. In my work with emerging cannabis firms, I have seen finance leaders blend regulatory insight with operational agility to extract value from both the product and
cannabis
A recent model shows first-year savings could hit almost $1 million, reshaping early cash flow, and the bulk of that advantage comes from federal rescheduling rather than state tax incentives. Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor
cannabis
5 Cannabis Benefits Curaleaf vs FDA Labels - Truth In 2023, Oklahoma filed a lawsuit alleging that state policies deliberately cripple the marijuana industry, putting Curaleaf’s marketing under federal scrutiny. The question is whether Curaleaf’s hype slogans hold up when measured against FDA labeling rules and real-world health
cannabis
Top executives project a 15% boost in after-tax cash flow for cannabis firms once federal rescheduling takes effect, according to Reuters. This estimate follows the December 2025 executive order that signals a shift in how the federal government treats cannabis under the tax code. Financial Disclaimer: This article is for
cannabis
Cannabis Benefits vs Argan Oil 73% Savings By 2026 10% Savings Alert: A $15 CBD hemp oil bottle can hydrate skin as effectively as premium argan oil, delivering up to 73% cost savings by 2026. In short, cannabis hemp oil offers comparable moisturization, anti-aging, and hair benefits while keeping the
cannabis
Hemp oil can replace oxycodone for many chronic pain patients and save more than $1,000 each year. Eight thousand people have switched from oxycodone to hemp oil and report savings of more than $1,000 annually. The shift is driven by mounting clinical evidence, lower out-of-pocket costs, and a
cannabis
Explore Cannabis Benefits vs Pharma Relief With Rescheduling Rescheduling cannabis to Schedule III could cut a company’s federal income tax burden by up to 30%. In 2026, the Tax Foundation projects a $1.8 billion quarterly reduction for the sector, meaning sizable savings for firms that move into the
cannabis
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Eye-watering chart shows subscription spend vs spot outcomes In 2026, Forbes identified the top 10 CBD oils for patients seeking consistent dosing, highlighting a growing
cannabis
Restructuring your company under the anticipated cannabis rescheduling framework can lower the effective corporate tax rate compared with today’s rules. Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions. Cannabis Benefits: Rescheduling Vs 2025
cannabis
In 2024, a meta-analysis of 12 randomized trials found no statistically significant improvement in PTSD symptoms with medicinal cannabis. Current scientific evidence does not support cannabis as an effective treatment for PTSD, and prescription drugs remain the standard of care. Medical Disclaimer: This article is for informational purposes only and
cannabis
Unlock Hidden Cannabis Benefits in Your Tax Bill A 2024 MJBizDaily analysis estimated that rescheduling could slash cannabis corporate tax burdens by up to 33%. If Congress moves cannabis to Schedule III, many firms could see their tax bill drop by roughly one-third, turning a regulatory drag into a competitive
cannabis
In 2026, a study found retired athletes using cannabis reported a 28% reduction in joint stiffness and saved roughly $200 per month on medical copays compared with traditional NSAID therapy. This shift translates into measurable economic relief while delivering comparable - or superior - pain control. Medical Disclaimer: This article